S2E9: Hormone Therapy | Aromatase Inhibitors | Ovarian Suppression
Manage episode 353131439 series 3439740
The anticipation is here. We discuss the dreading topic of endocrine therapy to help slow and stop cancer cell growth for the next 5-10 years. From early menopause w/ovarian suppression (which can be reversible) to the not-so-great side effects, we talk about it all in this episode. Rosalina and Shauna have two completely different plans, which makes it interesting to learn more about their approach post-cancer treatment.
Resources:
HormoneTherapy: https://www.breastcancer.org/treatment/hormonal-therapy
CDK 4/6 inhibitor (Verzenio - FDA approved to be used for early-stage breast cancer) - https://www.breastcancer.org/research-news/verzenio-approved-to-treat-early-hr-pos-bc-with-high-risk-of-recurrence
Zometa infusion (to strengthen bones): https://www.cancernetwork.com/view/early-efficacy-observed-with-trastuzumab-deruxtecan-pertuzumab-for-her2-metastatic-breast-cancer
If you enjoy this episode, please share it with your friends. Help us reach more women by subscribing and rating us on Apple Podcast, Spotify, and YouTube.
You can follow us on Instagram @TYFTSpodcast and email us at tyftspodcast@gmail.com
Visit our website, and check out our resources: https://tyftspodcast.com/
59 episoade